These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 1400928)

  • 21. Evidence for a stimulatory role of high doses of recombinant human follicle-stimulating hormone in the treatment of male-factor infertility.
    Paradisi R; Natali F; Fabbri R; Battaglia C; Seracchioli R; Venturoli S
    Andrologia; 2014; 46(9):1067-72. PubMed ID: 24215716
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Testicular function in a birth cohort of young men.
    Hart RJ; Doherty DA; McLachlan RI; Walls ML; Keelan JA; Dickinson JE; Skakkebaek NE; Norman RJ; Handelsman DJ
    Hum Reprod; 2015 Dec; 30(12):2713-24. PubMed ID: 26409015
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nonsupplemented luteal phase characteristics after the administration of recombinant human chorionic gonadotropin, recombinant luteinizing hormone, or gonadotropin-releasing hormone (GnRH) agonist to induce final oocyte maturation in in vitro fertilization patients after ovarian stimulation with recombinant follicle-stimulating hormone and GnRH antagonist cotreatment.
    Beckers NG; Macklon NS; Eijkemans MJ; Ludwig M; Felberbaum RE; Diedrich K; Bustion S; Loumaye E; Fauser BC
    J Clin Endocrinol Metab; 2003 Sep; 88(9):4186-92. PubMed ID: 12970285
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effect of concentration of circulating luteinizing hormone in late-follicle phase on the outcome of in vitro fertilization for normogonadotrophic women].
    Sun H; Hu Y; Wang B; Chen Q; Zhang N; Chen H; Wang J; Xu Z
    Zhonghua Nan Ke Xue; 2004 Dec; 10(12):912-5. PubMed ID: 15638021
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of chronic testosterone administration in normal men: safety and efficacy of high dosage testosterone and parallel dose-dependent suppression of luteinizing hormone, follicle-stimulating hormone, and sperm production.
    Matsumoto AM
    J Clin Endocrinol Metab; 1990 Jan; 70(1):282-7. PubMed ID: 2104626
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endocrinology of male infertility.
    de Kretser DM
    Br Med Bull; 1979 May; 35(2):187-92. PubMed ID: 387166
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Can the fall in serum FSH during coasting in IVF/ICSI predict clinical outcomes?
    Datta AK; Zosmer A; Tozer A; Sabatini L; Davis C; Al-Shawaf T
    Reprod Biomed Online; 2012 May; 24(5):503-10. PubMed ID: 22417663
    [TBL] [Abstract][Full Text] [Related]  

  • 28. WITHDRAWN: Recombinant versus urinary follicle stimulating hormone for ovarian stimulation in assisted reproduction cycles.
    Daya S; Gunby J
    Cochrane Database Syst Rev; 2007 Jul; 2006(3):CD002810. PubMed ID: 17636708
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recombinant versus urinary follicle stimulating hormone for ovarian stimulation in assisted reproduction cycles.
    Daya S; Gunby J
    Cochrane Database Syst Rev; 2000; (4):CD002810. PubMed ID: 11034767
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Follicular phase serum levels of luteinizing hormone do not influence delivery rates in in vitro fertilization cycles down-regulated with a gonadotropin-releasing hormone agonist and stimulated with recombinant follicle-stimulating hormone.
    Cabrera RA; Stadtmauer L; Mayer JF; Gibbons WE; Oehninger S
    Fertil Steril; 2005 Jan; 83(1):42-8. PubMed ID: 15652885
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of high basal FSH/LH ratio in women with normal FSH levels on in vitro fertilization outcomes.
    Lyu SW; Kim JW; Choi CH; Seok HH; Yoon TK; Kim A
    Gynecol Endocrinol; 2013 May; 29(5):424-9. PubMed ID: 23544714
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison between testosterone enanthate-induced azoospermia and oligozoospermia in a male contraceptive study. I: Plasma luteinizing hormone, follicle stimulating hormone, testosterone, estradiol, and inhibin concentrations.
    Wallace EM; Gow SM; Wu FC
    J Clin Endocrinol Metab; 1993 Jul; 77(1):290-3. PubMed ID: 8325955
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Future in vitro fertilization pregnancy potential of women with variably elevated day 3 follicle-stimulating hormone levels.
    Martin JS; Nisker JA; Tummon IS; Daniel SA; Auckland JL; Feyles V
    Fertil Steril; 1996 Jun; 65(6):1238-40. PubMed ID: 8641506
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Kinetic study of pulsatility of gonadotropin and testosterone secretion in normospermic fertile and infertile men with idiopathic oligo-asthenozoospermia].
    Chavarría E; Reyes A; Carrera A; Aguilera G; Rosado A; Veldhuis JD
    Ginecol Obstet Mex; 1995 Feb; 63():74-89. PubMed ID: 7698680
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of hormones on semen parameters in patients with idiopathic or varicocele-related oligoasthenoteratozoospermia (OAT) syndrome.
    Wei TC; Huang WJ; Lin AT; Chen KK
    J Chin Med Assoc; 2013 Nov; 76(11):624-8. PubMed ID: 23933342
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A randomized comparison of two ovarian stimulation protocols with gonadotropin-releasing hormone (GnRH) antagonist cotreatment for in vitro fertilization commencing recombinant follicle-stimulating hormone on cycle day 2 or 5 with the standard long GnRH agonist protocol.
    Hohmann FP; Macklon NS; Fauser BC
    J Clin Endocrinol Metab; 2003 Jan; 88(1):166-73. PubMed ID: 12519847
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pituitary-ovarian relationships preceding the menopause. I. A cross-sectional study of serum follice-stimulating hormone, luteinizing hormone, prolactin, estradiol, and progesterone levels.
    Reyes FI; Winter JS; Faiman C
    Am J Obstet Gynecol; 1977 Nov; 129(5):557-64. PubMed ID: 910845
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recombinant human follicle stimulating hormone for treatment of male idiopathic infertility: a randomized, double-blind, placebo-controlled, clinical trial.
    Kamischke A; Behre HM; Bergmann M; Simoni M; Schäfer T; Nieschlag E
    Hum Reprod; 1998 Mar; 13(3):596-603. PubMed ID: 9572419
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Potential of testosterone buciclate for male contraception: endocrine differences between responders and nonresponders.
    Behre HM; Baus S; Kliesch S; Keck C; Simoni M; Nieschlag E
    J Clin Endocrinol Metab; 1995 Aug; 80(8):2394-403. PubMed ID: 7543113
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Correlation between serum inhibin B level after treatment with gonadotropin releasing hormone agonist and outcome of in vitro fertilization-embryo transfer].
    Lin WQ; Yang HY; Lin JJ; Chen X; Ye BL
    Zhonghua Fu Chan Ke Za Zhi; 2009 Apr; 44(4):260-2. PubMed ID: 19570462
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.